Medical Devices

The design giant unveils its vision at Fulton Market, blending AI tools, iconic updates, and a deep commitment to sustainability across work, home, and health.

Autoliv's new Swedish Innovation Center isn't just an R&D lab; it's a strategic move to dominate the complex safety landscape of EVs and autonomous cars.

With CE Mark approval for its SOUND REACH Swift, Genesis MedTech brings a 'plug-and-play' ultrasonic shear to Europe, promising to simplify complex open surgeries.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

The cold storage giant's strategic acquisition of a pharma-certified specialist signals a major shift into the high-stakes world of medical logistics.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Former Samsung smartphone chief Blake Gaiser joins Eyesafe, signaling a major push to embed vision wellness tech into every device you own.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Following its X3D acquisition, Catalyst MedTech unveils an expanded portfolio and a new strategy to tackle aging equipment and modernize nuclear medicine.

A Chinese firm services ultrasound machines in 140+ countries, challenging OEM dominance and helping hospitals cut costs and extend equipment life.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

A skincare brand is challenging the FDA over sunscreen ingredients, revealing decades of regulatory delay and raising questions about what’s safe for our skin.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.

With child drownings on the rise, new federal funds aim to help local governments bolster pool safety, enforce laws, and prevent these tragic deaths.

Gene Solutions' AI-driven multi-omics liquid biopsy platform makes waves at a major oncology conference, finding a ready market in Taiwan.

Teva's new once-monthly olanzapine injection could revolutionize schizophrenia care in Europe, offering hope for better treatment adherence and patient outcomes.

Houston founder Dr. Bre Hayward is using her clinical expertise to redefine multicultural beauty with Baby Hair®, a brand built on scalp science and community.

Pioneers of IVF technology are launching a clinical skincare program, aiming to merge cellular science with holistic patient support in fertility clinics.

With new CEO Andrew Zeringue, Theromics aims to tackle cancer recurrence with its HeatSYNC gel, a novel approach in the booming ablation market.